EUVIMEDEUVIMED entdecken
Leserbrief

Methodological considerations in the UK Biobank diabetes‑tinnitus study

Axmedova Maxbuba, Abdurazakova Dilbar, Dilbar Urazbaeva, Sanjar Zaripov, Arman Abroumand Gholami iD

Acta Diabetologica · 04.08.2026 · 63 (12) · 2049-2051

DOI: 10.1007/s00592-026-02752-y ↗

Kurz gefasst

Leserbrief in der Zeitschrift Acta Diabetologica, online erschienen am 04.08.2026. Verfasst von Axmedova Maxbuba und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Therapy and Endocrinology, Samarkand state Medical University, Samarkand, Uzbekistan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Tinnitus. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tinnitus is a common and often debilitating condition that substantially affects quality of life. While diabetes has been suggested as a potential risk factor, the relationship remains poorly understood, particularly in large population-based settings where classification of diabetes type often relies on algorithms rather than confirmatory biomarkers. The recent UK Biobank study by Ji and colleagues addresses this gap by reporting that type 2 diabetes is associated with higher tinnitus prevalence. While the study benefits from a large sample and systematic examination of diabetes-related factors, two methodological concerns warrant consideration before the findings are interpreted as robust evidence. First, diabetes type was determined using algorithmic classification without confirmatory biomarkers such as autoantibodies or C-peptide. Second, the analytical strategy treated age as a simple covariate, implicitly assuming that the diabetes-tinnitus association remains constant across the entire 40-70 year age range. While the study offers valuable hypothesis-generating data, these methodological considerations suggest that the reported associations should be interpreted cautiously until confirmed by biomarker-validated phenotyping and more flexible analytical approaches that account for age-related heterogeneity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2TinnitusHumansUnited KingdomBiological Specimen BanksAgedMiddle AgedUK BiobankBiomarkersAdultFemaleMaleRisk Factors

Stichwörter der Autor:innen

Diabetes mellitusMethodological biasTinnitusUK Biobank

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Hospital Therapy and Endocrinology, Samarkand state Medical University, Samarkand, Uzbekistan.
  • Department of Hospital Therapy and Endocrinology, Andijan State Medical Institute, Andijan, Uzbekistan.
  • Department of Psychology and Medicine, Mamun university, Urgench, Uzbekistan.
  • Department of Internal medicine in family medicine, Tashkent State Medical University, Tashkent, Uzbekistan.
  • Nervous System Stem Cell Research Center, Semnan University of Medical Sciences, Semnan, Iran. aroma3162@gmail.com.
  • Department of Anatomy and Cell Biology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. aroma3162@gmail.com.

ORCID-Profile: Arman Abroumand Gholami

Zitieren

APA

Maxbuba, A., Dilbar, A., Urazbaeva, D., Zaripov, S., & Gholami, A. A. (2026). Methodological considerations in the UK Biobank diabetes‑tinnitus study. Acta Diabetologica, 63(12), 2049-2051. https://doi.org/10.1007/s00592-026-02752-y

Vancouver

Maxbuba A, Dilbar A, Urazbaeva D, Zaripov S, Gholami AA. Methodological considerations in the UK Biobank diabetes‑tinnitus study. Acta Diabetologica. 2026;63(12):2049-2051. doi:10.1007/s00592-026-02752-y

BibTeX
@article{Maxbuba2026,
  author = {Maxbuba, Axmedova and Dilbar, Abdurazakova and Urazbaeva, Dilbar and Zaripov, Sanjar and Gholami, Arman Abroumand},
  title = {Methodological considerations in the UK Biobank diabetes‑tinnitus study},
  journal = {Acta Diabetologica},
  year = {2026},
  volume = {63},
  number = {12},
  pages = {2049--2051},
  doi = {10.1007/s00592-026-02752-y}
}
Kostenlos starten →